Clinical Trial Detail
| NCT ID | NCT02657434 |
| Title | A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies |
Cisplatin + Pemetrexed Disodium Carboplatin + Pemetrexed Disodium |
| Age Groups: | adult senior |
CKB BOOST